Back to Search Start Over

Grouping of short alkyl-chain branched carboxylic acids for developmental toxicity.

Authors :
Colnot T
Dekant W
Source :
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2024 Aug; Vol. 151, pp. 105662. Date of Electronic Publication: 2024 Jun 11.
Publication Year :
2024

Abstract

Read-across (RAx) and grouping of chemicals into categories are well-known concepts in toxicology. Recently, ECHA proposed a grouping approach for branched-chain carboxylic acids (BCAs) including more than 60 branched-chain saturated carboxylic acids for hazard identification. Grouping was based only on structural considerations. Due to developmental effects of two members, ECHA postulated that "all short carbon chain acids … are likely reproductive and developmental toxicants". This work analyzes available data for BCAs. The number of compounds in the group can be significantly reduced by eliminating metal and organic salts of BCAs, compounds of unknown or variable composition, and complex reaction products or biological materials (UVCB compounds). For the resulting reduced number of compounds, grouping is supported by similar physicochemical data and expected similar biotransformation. However, analysis of adverse effects for compounds in the group and mechanistic information show that BCAs, as a class, do not cause developmental effects in rats. Rather, developmental toxicity is limited to selected BCAs with specific structures that share a common mode of action (histone deacetylase inhibition). Thus, the proposed grouping is unreasonably wide and the more detailed analyses show that structural similarity alone is not sufficient for grouping branched-chain carboxylic acids for developmental toxicity.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Each author certifies that their freedom to design, conduct, interpret, and publish research was not compromised by the sponsor. No competing interests. Authors were compensated for their time spent on manuscript preparation based on their usual consulting fees.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1096-0295
Volume :
151
Database :
MEDLINE
Journal :
Regulatory toxicology and pharmacology : RTP
Publication Type :
Academic Journal
Accession number :
38866176
Full Text :
https://doi.org/10.1016/j.yrtph.2024.105662